EC secures 300 million doses of COVID-19 vaccine

In contrast to the US, which has already invested US$8.3bn into contracts with different vaccine makers developing potential COVID-19 jabs under...

Aicuris to launch AiCubator to fight AMR

Under the new AiCuris accelerator, Aicuris will finance young researchers, who develop resistance breaking antiinfectives to advance their projects....

Polyneuron Pharmaceuticals AG extends Series A financing

HBM Healthcare’s CHF14m investment brings Polyneuron Pharmaceuticals AG’s Series A round to a total of CHF 36.5m. Upon the financing, Dr Emil...

COVID-19 jab: EU signs contract with JNJ

Both parties didn't announce a price for the jab. However, according to JNJ’s deal with the US government, which ordered 100 million doses, the...

MiNA Therapeutic bags £23m financing

Mina Therapeutics plc’s Series A round was led by aMoon, Israel’s largest healthtech and life sciences venture fund, with participation from...

Vifor Pharma in US$100m licence deal with Cara Therapeutics

Under the licence deal with the US company Cara Therapeutics Inc., Swiss Vifor Pharma has acquired the US commercialisation rights for intravenous...

Bioversys bags €17.7m financing

The Series B financing was supported in part by goetzpartners securities Ltd and Mirabaud Securities Ltd. It  complements the CHF16.5m of...